文献速递帕金森病与运动障碍

帕金森病中左旋多巴诱导的运动障碍:睡眠至关重要

Levodopa-induced dyskinesia in Parkinson disease: Sleep matters.
PubMed 文献 · Ann Neurol · 2018-11-29

研究纳入36例不同阶段帕金森病患者(初治9例、进展期13例、运动障碍14例)和12名年龄匹配对照,进行整夜视频多导睡眠图-高密度脑电图及1周活动记录。结果发现除运动障碍组外,所有组在早期与晚期睡眠之间均表现出慢波活动(SWA)明显下降。作者认为运动障碍患者可能存在突触下调不足。

要点

  • 除运动障碍组外,其余各组早期至晚期睡眠均见慢波活动明显下降。
  • 运动障碍患者可能缺乏足够的突触下调。
  • 需进一步分析可增强皮层慢波活动的药物对左旋多巴诱导运动障碍的作用。

核心结论

  • 数据表明睡眠与帕金森病之间存在强烈的病理生理关联。
  • 鉴于慢波活动可能反映突触强度,数据提示运动障碍患者没有足够的突触下调。

研究设计与样本

  • 36例不同阶段帕金森病患者分为初治组(n=9)、进展期组(n=13)和运动障碍组(n=14),与年龄匹配对照组(n=12)比较。
  • 患者接受整夜视频多导睡眠图-高密度脑电图,之前进行1周活动记录。
  • 将非快速眼动睡眠的慢波活动内容按时间分为10等份(T1至T10),进行功率和源分析,T2-T3-T4为早期睡眠,T7-T8-T9为晚期睡眠。

主要发现

  • 除运动障碍组外,所有组在早期与晚期睡眠之间均表现出明确的慢波活动下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步分析以确定可增强皮层慢波活动的药物对左旋多巴诱导运动障碍的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The spectrum of clinical symptom changes during the course of Parkinson disease (PD). Levodopa therapy, while offering remarkable control of classical motor symptoms, causes abnormal involuntary movements as the disease progresses. This levodopa-induced dyskinesia (LID) has been associated with abnormal cortical plasticity. Because slow wave activity (SWA) of nonrapid eye movement (NREM) sleep underlies adjustment of cortical excitability, we sought to elucidate the relationship between this physiological process and LID. METHODS: Thirty-six patients at different stages of PD underwent whole-night video polysomnography-high-density electroencephalography (vPSG-hdEEG), preceded by 1 week of actigraphy. To represent the broad spectrum of the disease, patients were divided into 3 groups by disease stage-(1) de novo (n = 9), (2) advanced (n = 13), and (3) dyskinetic (DYS; n = 14)-were compared to an age-matched control group (n = 12). The SWA-NREM content of the vPSG-hdEEG was then temporally divided into 10 equal parts, from T1 to T10, and power and source analyses were performed. T2-T3-T4 were considered early sleep and were compared to T7-T8-T9, representing late sleep. RESULTS: We found that all groups, except the DYS group, manifested a clear-cut SWA decrease between early and late sleep. INTERPRETATION: Our data demonstrate a strong pathophysiological association between sleep and PD. Given that SWA may be a surrogate for synaptic strength, our data suggest that DYS patients do not have adequate synaptic downscaling. Further analysis is needed to determine the effect of drugs that can enhance cortical SWA in LID. Ann Neurol 2018;84:905-917.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Amato N, Manconi M, Möller JC, et al. Levodopa-induced dyskinesia in Parkinson disease: Sleep matters. Ann Neurol. 2018. PMID: 30328147. doi:10.1002/ana.25360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。